Judge Allows Teva To Launch Generic Herpes Drug

Law360, New York (September 5, 2007, 12:00 AM EDT) -- A New Jersey federal court judge has opened the door for Israel-based drug maker Teva Pharmaceutical Industries Ltd. to launch a generic version of genital herpes drug Famvir after denying Novartis AG’s bid for a preliminary injunction.

U.S. District Judge Dennis M. Cavanaugh ruled against Novartis’ request for an injunction on Wednesday in its patent infringement case against Teva. He said that the Swiss drug manufacturer’s patent — U.S. Patent Number 5,246,937 — was obvious and unenforceable based on the merits of the case.

“Plaintiffs needed...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.